CNSY

Cerenome, Inc.

$3.27

0.02 (0.54%) Today

0.41 (11.14%) After-hours

— up— down

Compare CNSY

Open

$3.55

Previous Close

$3.70

Day Range

$3.52 – $3.79

52-Week Range

$2.90 – $23.50

Volume

92.85K

Exchange

NasdaqCM

About CNSY

Cerenome, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Cerenome also commercialized a molecular diagnostic service, CNSide®.